Steve Chriscoe

Mr. Steve Chriscoe, Vice President, Project Management – United States has worked in clinical research since 1995 and has worked for WCT since February 2021.

He began his career as a CRA before moving into a Clinical Research Scientist role at a large pharmaceutical company, where he continued to monitor clinical trials in addition to doing study management and writing. Mr. Chriscoe first became a Project Manager over 20 years ago, and since that time has held a variety of roles in project management, clinical operations and development. He has experience working in larger pharma, small biotech, as well as the CRO industry.


Mr. Chriscoe has served in an oversight role or as Project Manager for a variety of programs in Oncology:

  • Phase I – IV, with a focus on early phase studies including FIH and dose escalation/expansion
  • Immuno-oncology as well as CAR-T therapies
  • Solid tumor types include breast, cervical, prostate, bladder, pancreas, head & neck, liver & lung
  • Liquid tumor types include NHL, AML, and CLL


Mr. Chriscoe also has project management & clinical development experience in AAV-based gene therapy for rare diseases such as Pompe disease, Huntington’s disease, MMA, muscular dystrophy and Angelman syndrome.  This includes experience from pre-clinical through registrational studies.


Mr. Chriscoe holds a Bachelor’s degree in Physical Education from the University of North Carolina-Wilmington, and a Master’s degree in Exercise Physiology from the University of North Carolina.